OACC — Oaktree Acquisition III Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00- $261.81m
- $260.64m
Annual balance sheet for Oaktree Acquisition III Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 1.36 | 1.43 |
| Prepaid Expenses | ||
| Total Current Assets | 1.56 | 1.55 |
| Other Long Term Assets | ||
| Total Assets | 195 | 203 |
| Payable / Accrued | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0.727 | 1.3 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 7.75 | 8.32 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 188 | 195 |
| Total Liabilities & Shareholders' Equity | 195 | 203 |
| Total Common Shares Outstanding |